Cargando…
A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
Glioma is a primary cranial malignancy with high recurrence rate, poor prognosis and high mortality. However, the roles of immunogenic cell death (ICD) in glioma remain unclear. Twenty ICD genes were analyzed to be differentially expressed between glioma tissues and non-tumor tissues in 371 glioma p...
Autores principales: | Zhang, Jianhua, Du, Jin, Jin, Zhihai, Qian, Jiang, Xu, Jinfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348309/ https://www.ncbi.nlm.nih.gov/pubmed/37456890 http://dx.doi.org/10.7717/peerj.15615 |
Ejemplares similares
-
Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients
por: Hu, Yan, et al.
Publicado: (2021) -
Novel pyroptosis-associated genes signature for predicting the prognosis of sarcoma and validation
por: Wen, Hao, et al.
Publicado: (2022) -
Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022) -
A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma
por: Wu, Zhengyuan, et al.
Publicado: (2021) -
High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment
por: Tian, Yixin, et al.
Publicado: (2020)